Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

ClinicalTrials.gov ID: NCT00196339

Public ClinicalTrials.gov record NCT00196339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to compare the efficacy and safety of 3 doses of DR-2031 to placebo when used as "add-on" therapy for prostate cancer patients with hot flashes following surgical or medical castration. All prostate cancer therapy must be stable for at least 45 days before entering the study and must remain stable throughout this 12-week study. Patients will maintain a daily paper diary to record the frequency and severity of hot flashes during the treatment period.

Study identification

NCT ID
NCT00196339
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duramed Research
Industry
Enrollment
315 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2005 (Type not available)
Primary completion
Jan 2008 (Actual)
Completion
Jan 2008 (Actual)
Last update posted
Jul 22, 2016

2005 – 2008

United States locations

U.S. sites
98
U.S. states
37
U.S. cities
90
Facility City State ZIP Site status
Duramed Investigational Site Birmingham Alabama 35209 —
Duramed Investigational Site Birmingham Alabama 35234 —
Duramed Investigational Site Homewood Alabama 35209 —
Duramed Investigational Site Huntsville Alabama 35801 —
Duramed Investigational Site Phoenix Arizona 85013 —
Duramed Investigational Site Tucson Arizona 85712 —
Duramed Investigational Site Little Rock Arkansas 72211 —
Duramed Investigational Site Anaheim California 92801 —
Duramed Investigational Site Fresno California 93720 —
Duramed Investigational Site La Mesa California 91942 —
Duramed Investigational Site Laguna Hills California 92653 —
Duramed Investigational Site Laguna Woods California 92637 —
Duramed Investigational Site Long Beach California 90806 —
Duramed Investigational Site Los Angeles California 90048 —
Duramed Investigational Site San Bernardino California 92404 —
Duramed Investigational Site San Diego California 92103 —
Duramed Investigational Site Torrance California 90505 —
Duramed Investigational Site Denver Colorado 80210 —
Duramed Investigational Site Denver Colorado 80211 —
Duramed Investigational Site Wheat Ridge Colorado 80033 —
Duramed Investigational Site Middlebury Connecticut 06762 —
Duramed Investigational Site New Britain Connecticut 06052 —
Duramed Investigational Site Trumbull Connecticut 06611 —
Duramed Investigational Site Waterbury Connecticut 06708 —
Duramed Investigational Site Washington D.C. District of Columbia 20307 —
Duramed Investigational Site Aventura Florida 33180 —
Duramed Investigational Site Daytona Beach Florida 32114 —
Duramed Investigational Site New Port Richey Florida 34652 —
Duramed Investigational Site Ocala Florida 34470 —
Duramed Investigational Site Ocala Florida 34471 —
Duramed Investiational Site Ocala Florida 34474 —
Duramed Investigational Site Plantation Florida 33324 —
Duramed Investigational Site Sarasota Florida 34237 —
Duramed Investigational Site Spring Hill Florida 34608 —
Duramed Investigational Site St. Petersburg Florida 33703 —
Duramed Investigational Site St. Petersburg Florida 33710 —
Duramed Investigational site Atlanta Georgia 30342 —
Duramed Investigational Site Coeur d'Alene Idaho 83814 —
Duramed Investigational Site Berwyn Illinois 60402 —
Duramed Investigational Site Chicago Illinois 60640 —
Duramed Investigational Site Kankakee Illinois 60901 —
Duramed Investigational Site Peoria Illinois 61614 —
Duramed Investigational Site Greenwood Indiana 46143 —
Duramed Investigational Site Jeffersonville Indiana 47130 —
Duramed Investigational Site Des Moines Iowa 50309 —
Duramed Investigational Site Overland Park Kansas 66211 —
Duramed Investigational Site New Orleans Louisiana 70121 —
Duramed Investigational Site Shreveport Louisiana 71106 —
Duramed Investigational Site Greenbelt Maryland 20770 —
Duramed Investigational Site Newton Massachusetts 02462 —
Duramed Investigational Site Watertown Massachusetts 02472 —
Duramed Investigational Site Saint Joseph Michigan 49085 —
Duramed Investigational Site Sartell Minnesota 56377 —
Duramed Investigational Site Jackson Mississippi 39202 —
Duramed Investigational Site St Louis Missouri 63141 —
Duramed Investigational Site Las Vegas Nevada 89109 —
Duramed Investigational Site Brick New Jersey 08724 —
Duramed Investigational Site Edison New Jersey 08837 —
Duramed Investigational Site Lawrenceville New Jersey 08648 —
Duramed Investigational Site Albany New York 12208 —
Duramed Investigational Site Bay Shore New York 11706 —
Duramed Investigational Site Elmont New York 11003 —
Duramed Investigational site Garden City New York 11530 —
Duramed Investigational Site New York New York 10016 —
Duramed Investigational Site Poughkeepsie New York 12601 —
Duramed Investigational Site Staten Island New York 10304 —
Duramed Investigational Site Williamsville New York 14221 —
Duramed Investigational Site Asheboro North Carolina 27203 —
Duramed Investigational Site Concord North Carolina 28025 —
Duramed Investigational Site Raleigh North Carolina 27607 —
Duramed Investigational Site Fargo North Dakota 58104 —
Duramed Investigational Site Canfield Ohio 44406 —
Duramed Investigational Site Canton Ohio 44718 —
Duramed Investigational Site Cincinnati Ohio 45212 —
Duramed Investigational Site Bethany Oklahoma 73008 —
Duramed Investigational Site Oklahoma City Oklahoma 73112 —
Duramed Investigational Site Allentown Pennsylvania 18103 —
Duramed Investigational Site Bala-Cynwyd Pennsylvania 19004 —
Duramed Investigational Site Lancaster Pennsylvania 17604 —
Duramed Investigational Site Philadelphia Pennsylvania 19115 —
Duramed Investigational Site Pittsburgh Pennsylvania 15212 —
Duramed Investigational Site Pittsburgh Pennsylvania 15232 —
Duramed Investigational Site Sellersville Pennsylvania 18960 —
Duramed Investigational Site State College Pennsylvania 16801 —
Duramed Investigational Site Providence Rhode Island 02904 —
Duramed Investigational Site Charleston South Carolina 29425 —
Duramed Investigational Site Knoxville Tennessee 37920 —
Duramed Investigational Site Austin Texas 78705 —
Duramed Investigational Site Dallas Texas 75231 —
Duramed Investigational Site Houston Texas 77074 —
Duramed Investigational Site San Antonio Texas 78229 —
Duramed Investigational Site Salt Lake City Utah 84107 —
Duramed Investigational Site Salt Lake City Utah 84124 —
Duramed Investigational Site Richmond Virginia 23235 —
Duramed Investigational Site Seattle Washington 98166 —
Duramed Investigational Site Tacoma Washington 98405 —
Duramed Investigational Site Tacoma Washington 98431 —
Duramed Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2016 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00196339 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →